심혈관 중재시술 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 지역별, 부문별 예측(2026-2033년)

Interventional Cardiology Devices Market Summary

The global interventional cardiology devices market size was estimated at USD 11.28 billion in 2025 and is projected to reach USD 19.75 billion by 2033, growing at a CAGR of 7.30% from 2026 to 2033. The market growth is driven by the rising prevalence of cardiovascular diseases, demand for minimally invasive procedures, and advancements in technologies such as drug-eluting stents and bioresorbable vascular scaffolds.

The expanding elderly population, rising healthcare spending, and improved access to cardiac care in emerging markets also contribute to market expansion. In May 2025, Mentice secured a USD 642,000 order from a top 20 global MedTech company to expand its simulation-based training solutions for interventional cardiology. The order highlights the growing demand for advanced procedural training tools designed to enhance clinician proficiency and patient safety.

The rising prevalence of cardiovascular diseases is a primary driver of the interventional cardiology devices industry growth. Sedentary lifestyles, poor dietary habits, and increasing rates of obesity and diabetes have led to a global surge in coronary artery disease and other cardiac conditions. This growing disease burden has increased the demand for timely and effective interventions, boosting the adoption of stents, catheters, and other interventional tools.In October 2024, the CDC reported that heart disease continues to be the top cause of death in the U.S., responsible for more than 919,000 deaths in 2023, or roughly one-third of all fatalities. A person dies from cardiovascular disease every 34 seconds, and around 5% of adults are affected by coronary artery disease. Between 2020 and 2021, heart disease incurred a financial toll of USD 417.9 billion in healthcare costs, medications, and lost productivity.

Global Interventional Cardiology Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country-level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global Interventional cardiology devices market report based on product and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Coronary Stents
  • DES
  • BMS
  • BRS
• PTCA Balloon Catheters
  • Normal
  • Specialty
  • Drug-Coated
• Intravascular Imaging Catheters and Pressure Guidewires
• Accessory Devices
  • PTCA Guidewires
  • PTCA Guiding Catheters
  • Introducer Sheaths
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • Thailand
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
• 2.3. Competitive Insights

Chapter 3. Global Interventional Cardiology Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Interventional Cardiology Devices: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Landscape
• 3.5. Case Study Analysis

Chapter 4. Global Interventional Cardiology Devices Market Segment Analysis, By Product, 2021-2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Interventional Cardiology Devices Market, by Product, 2021 to 2033
• 4.5. Coronary Stents
  • 4.5.1. Coronary stents market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.2. DES
    • 4.5.2.1. DES market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.3. BMS
    • 4.5.3.1. BMS market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.4. BRS
    • 4.5.4.1. BRS market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. PTCA Balloon Catheters
  • 4.6.1. PTCA balloon catheters market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.2. Normal
    • 4.6.2.1. Normal market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.3. Specialty
    • 4.6.3.1. Specialty market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.4. Drug-Coated
    • 4.6.4.1. Drug-coated market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. Intravascular Imaging Catheters and Pressure Guidewires
  • 4.7.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.8. Accessory devices
  • 4.8.1. Accessory devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8.2. PTCA Guidewires
    • 4.8.2.1. PTCA guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8.3. PTCA Guiding Catheters
    • 4.8.3.1. PTCA guiding catheters market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8.4. Introducer Sheaths
    • 4.8.4.1. Introducer sheaths market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Interventional Cardiology Devices Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 5.1. Regional Market Share Analysis, 2025 & 2033
• 5.2. Regional Market Dashboard
• 5.3. Regional Market Snapshot
• 5.4. Interventional Cardiology Devices Market Share by Region, 2025 & 2033
• 5.5. North America
  • 5.5.1. North America Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.5.2. U.S.
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Regulatory Scenario
    • 5.5.2.3. Competitive Scenario
    • 5.5.2.4. U.S. Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.5.3. Canada
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Regulatory Scenario
    • 5.5.3.3. Competitive Scenario
    • 5.5.3.4. Canada Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.5.4. Mexico
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Regulatory Scenario
    • 5.5.4.3. Competitive Scenario
    • 5.5.4.4. Mexico Interventional cardiology devices market, 2021 - 2033 (USD Million)
• 5.6. Europe
  • 5.6.1. Europe Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.6.2. UK
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Regulatory Scenario
    • 5.6.2.3. Competitive Scenario
    • 5.6.2.4. UK Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.6.3. Germany
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Regulatory Scenario
    • 5.6.3.3. Competitive Scenario
    • 5.6.3.4. Germany Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.6.4. France
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Regulatory Scenario
    • 5.6.4.3. Competitive Scenario
    • 5.6.4.4. France Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.6.5. Italy
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Regulatory Scenario
    • 5.6.5.3. Competitive Scenario
    • 5.6.5.4. Italy Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.6.6. Spain
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Regulatory Scenario
    • 5.6.6.3. Competitive Scenario
    • 5.6.6.4. Spain Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.6.7. Norway
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Regulatory Scenario
    • 5.6.7.3. Competitive Scenario
    • 5.6.7.4. Norway Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.6.8. Sweden
    • 5.6.8.1. Key Country Dynamics
    • 5.6.8.2. Regulatory Scenario
    • 5.6.8.3. Competitive Scenario
    • 5.6.8.4. Sweden Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.6.9. Denmark
    • 5.6.9.1. Key Country Dynamics
    • 5.6.9.2. Regulatory Scenario
    • 5.6.9.3. Competitive Scenario
    • 5.6.9.4. Denmark Interventional cardiology devices market, 2021 - 2033 (USD Million)
• 5.7. Asia Pacific
  • 5.7.1. Japan
    • 5.7.1.1. Key Country Dynamics
    • 5.7.1.2. Regulatory Scenario
    • 5.7.1.3. Competitive Scenario
    • 5.7.1.4. Japan Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.7.2. China
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Regulatory Scenario
    • 5.7.2.3. Competitive Scenario
    • 5.7.2.4. China Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.7.3. India
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Regulatory Scenario
    • 5.7.3.3. Competitive Scenario
    • 5.7.3.4. India Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.7.4. Australia
    • 5.7.4.1. Key Country Dynamics
    • 5.7.4.2. Regulatory Scenario
    • 5.7.4.3. Competitive Scenario
    • 5.7.4.4. Australia Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.7.5. South Korea
    • 5.7.5.1. Key Country Dynamics
    • 5.7.5.2. Regulatory Scenario
    • 5.7.5.3. Competitive Scenario
    • 5.7.5.4. South Korea Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.7.6. Thailand
    • 5.7.6.1. Key Country Dynamics
    • 5.7.6.2. Regulatory Scenario
    • 5.7.6.3. Competitive Scenario
    • 5.7.6.4. Thailand Interventional cardiology devices market, 2021 - 2033 (USD Million)
• 5.8. Latin America
  • 5.8.1. Brazil
    • 5.8.1.1. Key Country Dynamics
    • 5.8.1.2. Regulatory Scenario
    • 5.8.1.3. Competitive Scenario
    • 5.8.1.4. Brazil Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.8.2. Argentina
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Regulatory Scenario
    • 5.8.2.3. Competitive Scenario
    • 5.8.2.4. Argentina Interventional cardiology devices market, 2021 - 2033 (USD Million)
• 5.9. MEA
  • 5.9.1. South Africa
    • 5.9.1.1. Key Country Dynamics
    • 5.9.1.2. Regulatory Scenario
    • 5.9.1.3. Competitive Scenario
    • 5.9.1.4. South Africa Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.9.2. Saudi Arabia
    • 5.9.2.1. Key Country Dynamics
    • 5.9.2.2. Regulatory Scenario
    • 5.9.2.3. Competitive Scenario
    • 5.9.2.4. Saudi Arabia Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.9.3. UAE
    • 5.9.3.1. Key Country Dynamics
    • 5.9.3.2. Regulatory Scenario
    • 5.9.3.3. Competitive Scenario
    • 5.9.3.4. UAE Interventional cardiology devices market, 2021 - 2033 (USD Million)
  • 5.9.4. Kuwait
    • 5.9.4.1. Key Country Dynamics
    • 5.9.4.2. Regulatory Scenario
    • 5.9.4.3. Competitive Scenario
    • 5.9.4.4. Kuwait Interventional cardiology devices market, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company Categorization
• 6.3. Company Profiles
  • 6.3.1. Abbott
    • 6.3.1.1. Company overview
    • 6.3.1.2. Financial performance
    • 6.3.1.3. Product benchmarking
    • 6.3.1.4. Strategic initiatives
  • 6.3.2. Medtronic
    • 6.3.2.1. Company overview
    • 6.3.2.2. Financial performance
    • 6.3.2.3. Product benchmarking
    • 6.3.2.4. Strategic initiatives
  • 6.3.3. Boston Scientific Corporation
    • 6.3.3.1. Company overview
    • 6.3.3.2. Financial performance
    • 6.3.3.3. Product benchmarking
    • 6.3.3.4. Strategic initiatives
  • 6.3.4. Cardinal Health, Inc.
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Product benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. Koninklijke Philips N.V.
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Product benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. Terumo Corporation
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Product benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. Alvimedica Medical Technologies Inc.
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Product benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. Teleflex Incorporated
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Product benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. B. Braun Melsungen AG
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Product benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Biosensors International Group, Ltd.
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Product benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. Meril Life Sciences Pvt. Ltd.
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Product benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. BIOTRONIK SE & Co. KG.
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Product benchmarking
    • 6.3.12.4. Strategic initiatives
  • 6.3.13. ACIST Medical Systems, Inc.
    • 6.3.13.1. Company overview
    • 6.3.13.2. Financial performance
    • 6.3.13.3. Product benchmarking
    • 6.3.13.4. Strategic initiatives
  • 6.3.14. Asahi Intecc Co., Ltd.
    • 6.3.14.1. Company overview
    • 6.3.14.2. Financial performance
    • 6.3.14.3. Product benchmarking
    • 6.3.14.4. Strategic initiatives
  • 6.3.15. Cook Medical LLC
    • 6.3.15.1. Company overview
    • 6.3.15.2. Financial performance
    • 6.3.15.3. Product benchmarking
    • 6.3.15.4. Strategic initiatives
  • 6.3.16. Medinol Ltd.
    • 6.3.16.1. Company overview
    • 6.3.16.2. Financial performance
    • 6.3.16.3. Product benchmarking
    • 6.3.16.4. Strategic initiatives
  • 6.3.17. Merit Medical Systems, Inc.
    • 6.3.17.1. Company overview
    • 6.3.17.2. Financial performance
    • 6.3.17.3. Product benchmarking
    • 6.3.17.4. Strategic initiatives
  • 6.3.18. NuMED, Inc.
    • 6.3.18.1. Company overview
    • 6.3.18.2. Financial performance
    • 6.3.18.3. Product benchmarking
    • 6.3.18.4. Strategic initiatives
  • 6.3.19. OpSens Inc.
    • 6.3.19.1. Company overview
    • 6.3.19.2. Financial performance
    • 6.3.19.3. Product benchmarking
    • 6.3.19.4. Strategic initiatives
  • 6.3.20. Zeon Medical Inc.
    • 6.3.20.1. Company overview
    • 6.3.20.2. Financial performance
    • 6.3.20.3. Product benchmarking
    • 6.3.20.4. Strategic initiatives